Learn More
Medchemexpress LLC WRW4 | 878557-55-2 | 99.8% | 1104.27 | 5 MG

Supplier: Medchemexpress LLC HYP11195MG
WRW4 is a specific formyl peptide receptor-like 1 (FPRL1) antagonist. It inhibits WKYMVm binding to FPRL1 with an IC50 of 0.23 μM. WRW4 specifically inhibits the increase in intracellular calcium by the FPRL1 agonists MMK-1, amyloid beta42 (Abeta42) peptide, and F peptide.
- Specifically inhibits FPRL1, a receptor involved in various cellular processes.
- Inhibits Abeta42 peptide-induced superoxide generation and chemotactic migration of neutrophils.
- Completely inhibits the internalization of Abeta42 peptide in human macrophages.
- Blocks ERK phosphorylation downstream of FPRL1, which is induced by WKYMVm.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.